News Pfizer/BioNTech begin phase 1 of COVID-19/influenza combo BioNTech and Pfizer have announced that they are initiating a phase 1 study to evaluate a single dose mRNA-based combination
Sales & Marketing Rewiring commercialisation to meet the moment, with Helen Sa... At the Informa Biotech Showcase at JPM2026, EVERSANA President Greg Skalicky and Helen Sabzevari, CEO of Precigen, discuss new commercialisation.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
